Login or Register to unlock everything MedSchool has to offer!
Full Drug List
 

#

A

B

C

D

E

F

G

H

I

K

N

O

P

Q

R

S

T

U

V

W

Z

 
 

Palbociclib

  •  
    Oral
    Palbociclib
    Ibrance 
    • Mechanism of Action
    • Selectively inhibits cyclin-dependent kinase (CDK) 4 and 6, which act downstream of multiple mitogenic signalling pathways to stimulate cell proliferation.

Clinical Use

    • Indication
    • HER2 negative, ER / PR positive advanced or metastatic breast cancer in men or postmenopausal women (in combination with an aromatase inhibitor).
    • Adverse Effects
    • Neutropaenia (~75% of cases)
    • Nausea / vomiting / diarrhoea
    • Fatigue
    • Alopecia
    • Rash
    • LFT derangement

Potential Indications
BETA

Breast Cancer
Feedback